Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pulmonary therapeutics Market Research Reports

Titlepublishedprice

Global Pneumonia Therapeutics Market Size, Status and Forecast 2025

By QYResearch Group
"...... SmithKline - Merck & Co - Allergan - Bayer AG - Novartis AG - Abbott - Lupin Pharmaceuticals, Inc. Market segment by Regions/Countries, this report covers - United States - EU......"
19-Jan-2018$3300

Global and Chinese Idiopathic Pulmonary Fibrosis Industry, 2018 Market Research Report

By Prof Research
"...... s of the Idiopathic Pulmonary Fibrosis manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, a......"
15-Jan-2018$3000

Global and Chinese Pneumonia Therapeutics Industry, 2017 Market Research Report

By Prof Research
"...... onia Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manuf......"
14-Dec-2017$3000

Global Pneumonia Therapeutics Market 2017-2021

By Technavio
"...... portant part of the global respiratory disorder drugs market. The treatment of pneumonia involves three major categories, namely, vaccines, drugs, and oxygen therapy. Oxygen therapy is often used as a supplement to other therapies when the patient fa......"
22-Nov-2017$3500

Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Idiopathic Pulmonary Fibrosis which can turn out to be......"
01-Nov-2017$2000

Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... uding their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Klebsiella Pneumoniae Infections which can turn ......"
01-Nov-2017$2000

Emphysema - Pipeline Insight, 2017

By Delve Insight
"...... A comparative pipeline therapeutics assessment of Emphysema by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area......."
01-Nov-2017$1250

Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ion, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Pulmonary Embolism which can turn out to be future prospective competitors f......"
01-Nov-2017$2000

Klebsiella Pneumoniae Infections - Pipeline Insight, 2017

By Delve Insight
"...... al, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Klebsiella Pneumoniae Infections by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has......"
01-Nov-2017$1250

Global Pneumonia Partnering 2010-2017

By Current Partnering
"...... br /> • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agree......"
01-Nov-2017$1495